Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 233 Records) |
| Query Trace: Neoplasms and CYP3A4[original query] |
|---|
| Effects of CYP3A4/5 and ABC transporter polymorphisms on osimertinib plasma concentrations in Japanese patients with non-small cell lung cancer. Investigational new drugs 2022 9 40 (6): 1254-1262. Yokota Hayato, Sato Kazuhiro, Sakamoto Sho, Okuda Yuji, Fukuda Natsuki, Asano Mariko, Takeda Masahide, Nakayama Katsutoshi, Miura Masato |
| An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer. Frontiers in pharmacology 2022 8 13 897951. Roncato Rossana, Gerratana Lorenzo, Palmero Lorenza, Gagno Sara, Poetto Ariana Soledad, Peruzzi Elena, Zanchetta Martina, Posocco Bianca, De Mattia Elena, Canil Giovanni, Alberti Martina, Orleni Marco, Toffoli Giuseppe, Puglisi Fabio, Cecchin Eri |
| Association of genetic polymorphisms of CYP3A4 and CYP2D6 with gefitinib-induced toxicities. Anti-cancer drugs 2022 Aug . Kwok Wang Chun, Lam David Chi Leung, Ip Mary Sau Man, Tam Terence Chi Chun, Ho James Chung M |
| Pharmacogenetics of taxane-induced neurotoxicity in breast cancer: Systematic review and meta-analysis. Clinical and translational science 2022 Jul . Guijosa Alberto, Freyria Ana, Espinosa-Fernandez Jose Rodrigo, Estrada-Mena Francisco J, Armenta-Quiroga Ana Sofía, Ortega-Treviño Maria Fernanda, Catalán Rodrigo, Antonio-Aguirre Bani, Villarreal-Garza Cynthia, Perez-Ortiz Andric |
| Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer. Frontiers in pharmacology 2022 13 918219. Tan Tingfei, Han Gongwei, Cheng Ziwei, Jiang Jiemei, Zhang Li, Xia Zitong, Wang Xinmeng, Xia Qu |
| Lack of association of CYP2B6 pharmacogenetics with cyclophosphamide toxicity in patients with cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2022 May . Hwang Mary, Medley Sarah, Shakeel Faisal, Vanderwerff Brett, Zawistowski Matthew, Kidwell Kelley M, Hertz Daniel |
| Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant. European journal of clinical pharmacology 2022 1 78 (4): 613-621. Hibino Hideyuki, Sakiyama Naomi, Makino Yoshinori, Makihara-Ando Reiko, Horinouchi Hidehito, Fujiwara Yutaka, Kanda Shintaro, Goto Yasushi, Yoshida Tatsuya, Okuma Yusuke, Shinno Yuki, Murakami Shuji, Hashimoto Hironobu, Akiyoshi Takeshi, Imaoka Ayuko, Ohe Yuichiro, Yamaguchi Masakazu, Ohtani Hisaka |
| Study on individualized analgesia guided by CYP3A4/5 polymorphisms in perioperative thoracoscopic surgery. American journal of translational research 2022 1 13 (12): 14211-14219. Wang Shengyan, Yao Yibing, Kong Min, Zhou Xuyan, Shen |
| Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 9 167 115479. Elena Peruzzi, Lorenzo Gerratana, Marcella Montico, Bianca Posocco, Serena Corsetti, Michele Bartoletti, Sara Gagno, Marco Orleni, Elena De Mattia, Massimo Baraldo, Erika Cecchin, Fabio Puglisi, Giuseppe Toffoli, Rossana Ronca |
| ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban. Drug design, development and therapy 2023 8 17 2513-2522. Hamin Kim, Tae-Jin Song, Jeong Yee, Dong-Hyeok Kim, Junbeom Park, Hye Sun Gw |
| Effect of Food and Polymorphisms in SLCO2B1, CYP3A4 and UGT1A4 on Pharmacokinetics of Abiraterone and its Metabolites in Chinese Volunteers. British journal of clinical pharmacology 2023 8 . Yixin Hu, Jianyuan Wu, Bingyu Cheng, Rongli You, Xueyan Yin, Guiying Chen, Ling Yang, Yang Zhang, Luqin Si, Hongliang Jiang, Yongjun Zhang, Jianying Huang, Jiangeng Hua |
| CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients. Clinical pharmacokinetics 2023 6 . Ruben A G van Eerden, Nikki S IJzerman, Milan van Meekeren, Esther Oomen-de Hoop, Niels A D Guchelaar, Andrea M W Visser, Maja Matic, Ron H N van Schaik, Peter de Bruijn, Dirk-Jan A R Moes, Pieter A Jobse, Hans Gelderblom, Alwin D R Huitema, Neeltje Steeghs, Ron H J Mathijssen, Stijn L W Koolen, |
| Is OPRM1 genotype a valuable predictor of VAS in patients undergoing laparoscopic radical resection of colorectal cancer with fentanyl? BMC anesthesiology 2023 5 23 (1): 173. Yan Zhou, Lei Cao, Yihui Yang, Yaoyi Gao, Yihao Li, Beili Wang, Baishen Pan, Jian Huang, Wei G |
| Cytochrome P450 oxidoreductase, POR, associated with severe paclitaxel-induced peripheral neuropathy in patients of European ancestry from ECOG-ACRIN E5103. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 5 . Fei Shen, Guanglong Jiang, Santosh Philips, Laura Gardner, Gloria Xue, Erica Cantor, Reynold C Ly, Wilberforce Osei, Xi Wu, Chau Dang, Donald Northfelt, Todd Skaar, Kathy D Miller, George W Sledge, Bryan P Schneid |
| Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer. EClinicalMedicine 2023 5 59 101955. G D Marijn Veerman, Rene J Boosman, Merel Jebbink, Esther Oomen-de Hoop, Anthonie J van der Wekken, Idris Bahce, Lizza E L Hendriks, Sander Croes, Christi M J Steendam, Evert de Jonge, Stijn L W Koolen, Neeltje Steeghs, Ron H N van Schaik, Egbert F Smit, Anne-Marie C Dingemans, Alwin D R Huitema, Ron H J Mathijss |
| Tamoxifen pharmacokinetics and pharmacodynamics in older patients with non-metastatic breast cancer. Breast cancer research and treatment 2023 4 . Souwer E T D, Sanchez-Spitman A, Moes D J A R, Gelderblom H, Swen J J, Portielje J E A, Guchelaar H J, van Gelder |
| Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer. International journal of molecular sciences 2023 3 24 (6): . Cantara Silvia, Dalmiglio Cristina, Marzocchi Carlotta, Sagnella Alfonso, Brilli Lucia, Trimarchi Andrea, Maino Fabio, Valerio Laura, Castagna Maria Graz |
| Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy. Cancers 2023 3 15 (5): . Urtasun Andrea, Olivera Gladys G, Sendra Luis, Aliño Salvador F, Berlanga Pablo, Gargallo Pablo, Hervás David, Balaguer Julia, Juan-Ribelles Antonio, Andrés María Del Mar, Cañete Adela, Herrero María Jo |
| Risk Factors for Rivaroxaban-Related Bleeding Events-Possible Role of Pharmacogenetics: Case Series. Pharmacy (Basel, Switzerland) 2023 2 11 (1): . Šimi?evi? Livija, Sliškovi? Ana Marija, Kirhmajer Majda Vrki?, Ganoci Lana, Holik Hrvoje, Pali? Jozefina, Samardži? Jure, Božina Tama |
| Effect of genetic polymorphisms on the pharmacokinetics of gefitinib in healthy Chinese volunteers. Xenobiotica; the fate of foreign compounds in biological systems 2023 12 1-28. Ying-Rong Chen, Xiang Yu, Li-Min Xu, Jue Mei, Meng-Li Tian, Min Xu, Qiu-Yue Jin, Li-Bing Ye, Shui-Xin Ya |
| Prediction of trough concentration and ALK occupancy in plasma and cerebrospinal fluid using physiologically based pharmacokinetic modeling of crizotinib, alectinib, and lorlatinib. Frontiers in pharmacology 2023 12 14 1234262. Bole Li, Shan Liu, Honglei Feng, Chunshuang Du, Liman Wei, Jie Zhang, Guangwei Jia, Chunnuan |
| CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients. Frontiers in pharmacology 2023 11 14 1222435. Teerapat Majam, Chonlaphat Sukasem, Thanyanan Reungwetwattana, Phichai Chansriwong, Chalirmporn Atasilp, Narumol Trachu, Thanaporn Thamrongjirapat, Rattanaporn Sukprasong, Jennis Meanwattha |
| Is higher docetaxel clearance in prostate cancer patients explained by higher CYP3A: An in vivo phenotyping study with midazolam. Journal of clinical pharmacology 2023 10 . Lisa T van der Heijden, Claire A Ribbers, M A C Vermunt, D Pluim, M Acda, M Tibben, H Rosing, J A J Douma, K Naipal, A M Bergman, J H Beijnen, A D R Huitema, F L Opd |
| Impact of Posaconazole and Diltiazem on Pharmacokinetics of Encorafenib, a BRAF V600 Kinase Inhibitor for Melanoma and Colorectal Cancer with BRAF Mutations. Clinical and translational science 2023 10 . Erik Hahn, Renae Chavira, Lance Wollenberg, Weiwei Tan, Micaela B Red |
| Genetic Association in CYP3A4 and CYP3A5 genes elevate the risk of Prostate Cancer. Annals of human biology 2023 1 1-19. Bellah Sm Faysal, Salam Md Abdus, Billah S M Saker, Karim Md Reza |
| Potential association of SULT2A1 and ABCG2 variant alleles with increased risk for palbociclib toxicity. Pharmacogenomics 2024 8 1-9. Chong Wang, Mary Hwang, Brandon Paulson, Doreen Mhandire, Sadat Ozair, Tracey L O'Connor, Shipra Gandhi, Kristopher M Attwood, Daniel L Hertz, Andrew Kl Go |
| Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer. Journal of translational medicine 2024 7 22 (1): 646. Christin Lund-Andersen, Annette Torgunrud, Chakravarthi Kanduri, Vegar J Dagenborg, Ida S Frøysnes, Mette M Larsen, Ben Davidson, Stein G Larsen, Kjersti Flatma |
| Identification of non-adherence to adjuvant letrozole using a population pharmacokinetics approach in hormone receptor-positive breast cancer patients. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2024 5 199 106809. Alicja Puszkiel, Florence Dalenc, Naïma Tafzi, Pierre Marquet, Marc Debled, William Jacot, Laurence Venat-Bouvet, Catherine Ferrer, Nadia Levasseur, Rodolphe Paulon, Jérôme Dauba, Alexandre Evrard, Vincent Mauriès, Thomas Filleron, Etienne Chatelut, Fabienne Thomas, Melanie White-Koni |
| Pharmacogenomic predictor of long-term residual chemotherapy-induced peripheral neuropathy in ovarian cancer survivors: A substudy of the GINECO Vivrovaire study. Gynecologic oncology 2024 5 187 139-144. M Zenatri, T Perennec, C Michon, F Gernier, J-M Grellard, F-X Piloquet, C Dubot-Poitelon, E Kalbacher, O Tredan, P Augereau, P Pautier, L Fey, F Joly, J-S Fren |
| CYP2C8 rs11572080 and CYP3A4 rs2740574 risk genotypes in paclitaxel-treated premenopausal breast cancer patients. Scientific reports 2024 4 14 (1): 7922. Hanaa R M Attia, Mahmoud M Kamel, Dina F Ayoub, Shereen H Abd El-Aziz, Mai M Abdel Wahed, Safa N Abd El-Fattah, Mahmoud A Ablel-Monem, Thanaa M Rabah, Amany Helal, Mona Hamed Ibrah |
- Page last reviewed:Feb 1, 2024
- Content source: